Non-Small Cell Lung Cancer | Oncology Today with Dr Neil Love: Management of MET-Altered Non-Small Cell Lung Cancer

Research To Practice | Oncology Videos · Nov 7, 2022 · 38m

Featuring an interview with Dr Rebecca Heist, including the following topics:

Mechanism of action and toxicity of amivantamab in patients with MET-driven non-small cell lung cancer (NSCLC) (0:00)

Potential role of MET inhibitors as pantumor treatment for MET-altered cancer (2:27)

Selection and sequencing of targeted therapy for patients with MET-altered NSCLC (5:24)

Managing MET-altered NSCLC in patients with brain metastases (7:55)

Immune checkpoint inhibitors and MET-targeted therapy for patients with NSCLC and MET alterations (9:27)

Case: A woman in her mid 60s with no smoking history and…